Soleno Therapeutics
Price & Volume
Stats
See more52W Range | $29.43-$90.31 |
Market Cap | $2.7B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $285M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $281.1M |
Diluted EPS | $1.93 |
News
See moreYahoo Finance • 24 days ago
Neurocrine Biosciences Reports First-Quarter 2026 Financial Results
Yahoo Finance • 24 days ago
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
Yahoo Finance • 24 days ago
Halper Sadeh LLC is Investigating Whether SLNO, APLS, HLX are Obtaining Fair Deals for their Shareholders
Yahoo Finance • 24 days ago
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—CZNL, HLX, APLS, and SLNO
About
CEO | Dr. Anish Bhatnagar M.D. |
Address | 100 Marine Parkway, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 182 |